HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Neti, P. V.S.V. Articles by Howell, R. W. Search for Related Content PubMed PubMed Citation Articles by Neti, P. V.S.V. Articles by Howell, R. W.

When May a Nonuniform Distribution of ¹³¹I Be Considered Uniform? An Experimental Basis for Multicellular Dosimetry

¹ Division of Radiation Research, Department of Radiology, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, New Jersey

To varying degrees, radiopharmaceuticals are distributed nonuniformly in tissue. At a macroscopic level, the radiopharmaceutical may appear to be uniformly distributed throughout the tissue. However, on closer inspection, not all cells in the tissue may be labeled with the radiopharmaceutical. Furthermore, the radioactivity in the cells may be localized only in certain compartments within the cell. This work uses a cell culture model to examine the impact of nonuniformities at the multicellular level on the lethal effects of ¹³¹I. Methods: A 3-dimensional tissue culture model was used to investigate the biologic effects of nonuniform distributions of ¹³¹I in a large population of mammalian cells. Chinese hamster V79 cells were labeled with ¹³¹I-iododeoxyuridine (¹³¹IdU), mixed with unlabeled cells, and multicellular clusters (4 x 10⁶ cells) were formed by gentle centrifugation. Thus, the labeled cells were randomly located in the cluster to achieve a uniform distribution of radioactivity at the macroscopic level, yet nonuniform at the multicellular level. The clusters were assembled as described and then maintained at 10.5°C for 72 h to allow ¹³¹I decays to accumulate. The clusters were then dismantled and the cells were plated for colony formation. Results: When 100% of the cells were labeled, the surviving fraction of cells in the cluster was exponentially dependent on the cluster activity down to 0.1% survival. In contrast, when 10% of the cells were labeled, it was observed that the survival fraction begins to saturate at about 1% survival. Absorbed-dose estimates reveal that the mean lethal cluster dose is 4.5, 5.7, and 6.4 Gy for 100%, 10%, and 1% labeling, respectively. Conclusion: These data indicate that when the distribution of ¹³¹I is uniform at the macroscopic level, but nonuniform at the multicellular level, the mean absorbed dose to a tissue element may not be a suitable quantity for use in predicting biologic effect. Rather, cellular and multicellular dosimetry approaches may be necessary to predict the biologic effects of incorporated ¹³¹I.

Key Words: ¹³¹I • iododeoxyuridine • dosimetry • multicellular cluster • V79 cells • survival

This article has been cited by other articles:

				R. W. Howell, P. V. S. V. Neti, M. Pinto, B. I. Gerashchenko, V. R. Narra, and E. I. Azzam Challenges and progress in predicting biological responses to incorporated radioactivity Radiat Prot Dosimetry, December 1, 2006; 122(1-4): 521 - 527. [Abstract] [Full Text] [PDF]

				P. V.S.V. Neti and R. W. Howell Log Normal Distribution of Cellular Uptake of Radioactivity: Implications for Biologic Responses to Radiopharmaceuticals J. Nucl. Med., June 1, 2006; 47(6): 1049 - 1058. [Abstract] [Full Text] [PDF]

				P. V.S.V. Neti and R. W. Howell Isolating Effects of Microscopic Nonuniform Distributions of 131I on Labeled and Unlabeled Cells J. Nucl. Med., June 1, 2004; 45(6): 1050 - 1058. [Abstract] [Full Text] [PDF]